Show simple item record

Sentinel lymph node biopsy for thin melanoma‐con

dc.contributor.authorSabel, Michael S.en_US
dc.date.accessioned2012-08-09T14:55:28Z
dc.date.available2013-10-18T17:47:30Zen_US
dc.date.issued2012-09-01en_US
dc.identifier.citationSabel, Michael S. (2012). "Sentinel lymph node biopsy for thin melanoma‐con." Journal of Surgical Oncology 106(3): 217-218. <http://hdl.handle.net/2027.42/92392>en_US
dc.identifier.issn0022-4790en_US
dc.identifier.issn1096-9098en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/92392
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.titleSentinel lymph node biopsy for thin melanoma‐conen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbsecondlevelSurgery and Anesthesiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationother3304 Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109. Fax: 734‐647‐9647.en_US
dc.identifier.pmid22488561en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/92392/1/23001_ftp.pdf
dc.identifier.doi10.1002/jso.23001en_US
dc.identifier.sourceJournal of Surgical Oncologyen_US
dc.identifier.citedreferenceBalch CM, Gershenwald JE, Seng‐jaw S, et al.: Final version of 2009 AJCC melanoma staging and classification. JCO 2009; 27: 6199 – 6206.en_US
dc.identifier.citedreferenceShada AL, McLeod MD, Slingluff CL: T1b status in melanoma using the 2010 AJCC staging system predicts recurrence but does not impact sentinel node positivity. JACS 2011; 213: S138.en_US
dc.identifier.citedreferenceAndtbacka RH, Gershenwald JE: Role of sentinel lymph node biopsy in patients with thin melanoma. J Natl Compr Cancer Netw 2009; 7: 307 – 317.en_US
dc.identifier.citedreferenceMorton DL, Thompson JF, Cochran AJ, et al.: Sentinel‐node biopsy or nodal observation in melanoma. NEJM 2006; 355: 1307 – 1317.en_US
dc.identifier.citedreferenceAgnese DM, Abdessalam SF, Burak WE, et al.: Cost‐effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery 2003; 134: 542 – 548.en_US
dc.identifier.citedreferenceBleicher RJ, Essner R, Foshag LJ, et al.: Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. J Clin Oncol 2003; 21: 1326 – 1331.en_US
dc.identifier.citedreferenceWong SL, Brady MS, Busam KJ, et al.: Results of sentinel lymph node biopsy in patients with thin melanoma. Ann Surg Oncol 2006; 13: 302 – 309.en_US
dc.identifier.citedreferencePaek SC, Griffith KA, Johnson TM, et al.: The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer 2007; 109: 100 – 108.en_US
dc.identifier.citedreferenceKesmodel SB, Karakousis CP, Botbyl JD, et al.: Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol 2005; 12: 449 – 458.en_US
dc.identifier.citedreferenceSpeijers MJ, Bastiaannet E, De Vries M, et al.: Age and its interaction with the prognostic value of tumor mitotic rate in melanoma patients. Ann Surg Oncol 2011; 18: S109.en_US
dc.identifier.citedreferenceLane K, Kempf A, Magno C, et al.: Regional differences in the use of sentinel lymph node biopsy for melanoma: A potential quality measure. Am Surg 2008; 74: 981 – 984.en_US
dc.identifier.citedreferenceBilimoria KY, Balch CM, Wayne JD, et al.: Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States. JCO 2009; 27: 1857 – 1863.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.